T 0843/22 (GA dosage regimen for MS 1/YEDA) of 07.02.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T084322.20240207
- Date of decision
- 7 February 2024
- Case number
- T 0843/22
- Petition for review of
- -
- Application number
- 17157735.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Dosing regimen for multiple sclerosis
- Applicant name
- Yeda Research and Development Co., Ltd.
- Opponent name
- Generics [UK] Limited (trading as Mylan)
Synthon B.V.
G. L. Pharma GmbH
Alvogen IPCo S.a.r.l. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Grounds for opposition - main request
Grounds for opposition - added subject-matter (yes)
Inventive step - auxiliary requests 1 and 5 (no)
Sufficiency of disclosure - auxiliary requests 2 to 4 (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.